Frost & Sullivan Releases the "2026 Industry Report on the Cerebrovascular Neurointerventional Medical Consumables Market"

Cerebrovascular diseases represent a primary health threat to the middle-aged and elderly population in China. The associated high rates of mortality and disability impose a profound economic and caregiving burden on both families and society. In this context, neurointerventional therapy has emerged as a pivotal minimally invasive modality. Guided by medical imaging and utilizing percutaneous catheterization techniques, it enables the diagnosis and treatment of lesions within the central nervous system and related anatomical regions, including the head, neck, spine, and spinal cord. Characterized by minimal trauma, superior safety, and significant efficacy, this therapy is gaining increasing prominence in cerebrovascular care. Driven by continuous innovation in medical consumables, rising patient awareness, and enhanced healthcare accessibility, China’s neurointerventional consumables market is poised for sustained expansion and exhibits robust developmental potential.